Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Cash from Operations (2019 - 2025)

Korro Bio's Cash from Operations history spans 7 years, with the latest figure at 17702000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 136.18% year-over-year to 17702000.0, compared with a TTM value of 78561000.0 through Dec 2025, down 30.77%, and an annual FY2025 reading of 78561000.0, down 30.77% over the prior year.
  • Cash from Operations for Q4 2025 was 17702000.0 at Korro Bio, down from 17179000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 7495000.0 in Q4 2024, with the low at 25474000.0 in Q1 2021.
  • Average Cash from Operations over 5 years is 16781100.0, with a median of 17261000.0 recorded in 2022.
  • Year-over-year, Cash from Operations crashed 172.07% in 2021 and then skyrocketed 64.49% in 2024.
  • Tracing KRRO's Cash from Operations over 5 years: stood at 17888000.0 in 2021, then skyrocketed by 38.36% to 11027000.0 in 2022, then crashed by 91.41% to 21107000.0 in 2023, then skyrocketed by 64.49% to 7495000.0 in 2024, then tumbled by 136.18% to 17702000.0 in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Cash from Operations are 17702000.0 (Q4 2025), 17179000.0 (Q3 2025), and 19228000.0 (Q2 2025).